Myla, Agila merger
Myla, Inc. and Agila Specialties would, between them, have to divest 11 generic injectable drugs as a condition of Myla’s purchase of Agila from Strides Arcolab under a proposed settlement approved...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch